November Legislative Update: HB 421/SB332 RPh Admin of Long-Acting Meds
Antonio Ciaccia, Director of Government & Public Affairs & Michelle Fitzgibbon, Lobbyist
SB 332/HB 421: Pharmacist Administration of Long-Acting Medications
OPA is currently pursuing legislation utilizing pharmacists to expand access of prescription drug administrators in Ohio.
This summer, after months of discussions with interested parties and Ohio House of Representatives member Rep. Sarah LaTourette’s (R-Bainbridge Township), HB 421 was successfully voted out of the House and has moved to the Senate. Because there are only two months left before the end of the 131st General Assembly, OPA is working hard to ensure that Rep. LaTourette’s language passes. In late September, OPA worked with Senator Gayle Manning (R-North Ridgeville) on drafting an amendment to take the language from HB 421 and replicate it in SB 332, a comprehensive infant mortality reform bill currently being championed by Senator Shannon Jones (R-Springboro) and Senator Charleta Tavares (D-Columbus).
OPA Director of Government & Public Affairs Antonio Ciaccia gave testimony in the Senate Health & Human Services Committee in support of Senator Manning’s amendment and SB 332. We’re pleased to report that we were successful in integrating Senator Manning’s amendment into SB 332, the bill was voted out of committee, and on September 28, SB 332 was voted out of the Senate and moves back to the House.
Thank you, OPA members, for your calls and emails to back-up our efforts to expand pharmacists’ scope of practice to better serve Ohioans.
As of now, we have two bills – HB 421 and SB 332 – that allow pharmacists (under a physician protocol) to administer by injection any of the following drugs, if the patient has a valid prescription for the drug:
- Any opioid antagonist used to treat drug addiction and administered in a long-acting or extended-release form;
- Any antipsychotic drug administered in a long-acting or extended-release form;
- Hydroxyprogesterone caproate (a prescription hormone used to lower the risk of preterm birth);
- Medroxyprogesterone acetate (a prescription contraceptive);
- Cobalamin (vitamin B12).
The bills also permit a pharmacist to administer epinephrine or diphenhydramine, or both, to an individual in an emergency resulting from any adverse reaction to a drug administration.
So what needs to happen next? As mentioned earlier, HB 421 has already passed the House, and it now sits in the Senate Health & Human Services Committee. And SB 332 has passed the Senate, and will now work its way over to the House. OPA is currently advocating for both bills. So please call your state representative, and ask for their support for SB 332, and call your state senator to ask for their support of HB 421. Visit the OPA Advocacy Action Center for complete details and to send a message to your elected officials: https://votervoice.net/OPA/campaigns.
Ohio Medical Marijuana Advisory Committee
With passage of HB 523, Ohio’s medical marijuana law, the state is creating a regulatory structure so that the drug will be ready for distribution in 2018 to patients legally allowed to obtain it. While OPA opposed the law, we are working to ensure that medical marijuana is as legitimate, appropriate, and safe as possible for Ohioans.
OPA has launched a special Medical Marijuana Task Force to make suggestions to improve the law, offer perspective on the regulatory process, and work to properly educate pharmacists and patients about the drug.
The State of Ohio Board of Pharmacy, the Ohio State Medical Board, and the Department of Commerce are responsible for drafting the regulations to implement the law in consultation with the newly created Ohio Medical Marijuana Advisory Committee. We are pleased to announce that the two pharmacist positions on the committee were filled by OPA members, Curtis Passafume and Stephanie Abel. Governor Kasich named Passafume as chair of the committee.
Stephanie Abel, R.Ph., PharmD, BCPS is Clinical Pharmacy Specialist for the Ohio State University James Cancer Center. Curt Passafume, R.Ph., MBA is the System Vice President for OhioHealth Pharmacy Services and also a member of the Board of Pharmacy.
For more information about the Ohio Medical Marijuana Control Program, visit http://www.medicalmarijuana.ohio.gov/.
Pharmacy Political Action Committee
Please consider financial support of our legislative efforts by contributing to the OPA Pharmacy PAC. One hundred percent of Pharmacy PAC money goes to help candidates who support pharmacy in Ohio. Visit http://bit.ly/OPA_PAC to make a donation!
For more information, contact Antonio Ciaccia at 614.389.3236 or email@example.com.
February 28, 2017
OPA Office- 2674 Federated Blvd, Columbus, OH 43235
February 28, 2017
March 7, 2017
OPA office- 2674 Federated Blvd, Columbus, OH 43235
April 21-23, 2017
Greater Columbus Convention Center, Columbus, OH
May 11, 2017
Makoy Center, 5462 Center Street, Hilliard, OH 43026